We are live on ! Find out more
MLL

Moody Lynn & Lieberson Portfolio holdings

AUM $1.9B
1-Year Est. Return 27.82%
This Fund
S&P 500
This Quarter Est. Return
+5.35%
1 Year Est. Return
+27.82%
3 Year Est. Return
+128.03%
5 Year Est. Return
+198.12%
10 Year Est. Return
+974.77%
AUM
$627M
AUM Growth
-$74.6M
Cap. Flow
-$91.7M
Cap. Flow %
-14.63%
Top 10 Hldgs %
29.41%
Holding
216
New
27
Increased
51
Reduced
75
Closed
35

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$16.7M
2
ECL icon
Ecolab
ECL
+$12.9M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$11.7M
4
AIG icon
American International
AIG
+$11.1M
5
BIDU icon
Baidu
BIDU
+$10.4M

Sector Composition

Rank Sector Weight
1 Healthcare 24.97%
2 Financials 14.33%
3 Consumer Discretionary 9.74%
4 Communication Services 8.1%
5 Technology 7.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIIB icon
1
Biogen
BIIB
$29.9B
$21.5M 3.43%
50,875
-436
-0.8% -$172K
AAPL icon
2
Apple
AAPL
$4.89T
$20.4M 3.26%
656,468
-38,296
-6% -$1.16M
EWG icon
3
iShares MSCI Germany ETF
EWG
$1.5B
$20.4M 3.25%
+683,561
New +$19.6M
MA icon
4
Mastercard
MA
$477B
$19.5M 3.11%
225,706
+44,646
+25% +$3.87M
AMGN icon
5
Amgen
AMGN
$203B
$18.9M 3.01%
117,975
-1,735
-1% -$273K
CELG
6
DELISTED
Celgene Corp
CELG
$18.6M 2.97%
161,382
-8,913
-5% -$1.07M
DIS icon
7
Walt Disney
DIS
$165B
$17.6M 2.8%
167,598
-10,814
-6% -$1.09M
VEA icon
8
Vanguard FTSE Developed Markets ETF
VEA
$226B
$16.8M 2.67%
420,997
+408,348
+3,228% +$16M
MDT icon
9
Medtronic
MDT
$107B
$15.9M 2.53%
203,620
-22,972
-10% -$1.74M
BRK.B icon
10
Berkshire Hathaway Class B
BRK.B
$1.07T
$14.9M 2.38%
103,317
-32,262
-24% -$4.75M
META icon
11
Meta Platforms (Facebook)
META
$1.51T
$13.9M 2.22%
169,185
+14,171
+9% +$1.11M
GPC icon
12
Genuine Parts
GPC
$17.1B
$12.3M 1.96%
131,911
-1,215
-0.9% -$117K
LOW icon
13
Lowe's Companies
LOW
$116B
$11.2M 1.79%
151,028
+580
+0.4% +$41.6K
WBA
14
DELISTED
Walgreens Boots Alliance
WBA
$11.2M 1.78%
132,093
-4,414
-3% -$352K
NKE icon
15
Nike
NKE
$61.9B
$10.5M 1.68%
210,220
-1,976
-0.9% -$94.5K
AGN
16
DELISTED
Allergan plc
AGN
$10.5M 1.68%
35,294
+6,133
+21% +$1.75M
WFC icon
17
Wells Fargo
WFC
$261B
$9.91M 1.58%
182,225
-1,594
-0.9% -$86.1K
NVS icon
18
Novartis
NVS
$295B
$9.9M 1.58%
+112,070
New +$9.94M
V icon
19
Visa
V
$677B
$9.77M 1.56%
149,420
+81,296
+119% +$5.38M
TRV icon
20
Travelers Companies
TRV
$80.8B
$9.56M 1.53%
88,448
+12,589
+17% +$1.34M
MRK icon
21
Merck
MRK
$324B
$9.51M 1.52%
173,392
-4,886
-3% -$277K
BA icon
22
Boeing
BA
$165B
$9.44M 1.51%
62,899
+11,193
+22% +$1.63M
UNP icon
23
Union Pacific
UNP
$183B
$9.29M 1.48%
85,810
-21,936
-20% -$2.57M
XOM icon
24
ExxonMobil
XOM
$651B
$9.27M 1.48%
109,039
-3,858
-3% -$342K
BLK icon
25
Blackrock
BLK
$164B
$9.25M 1.48%
25,282
+4,766
+23% +$1.73M

Similar funds

Moody Lynn & Lieberson's Q1 2015 Portfolio in Review

As of Q1 2015, Moody Lynn & Lieberson held 216 positions worth $627M, down 11% from $702M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Moody Lynn & Lieberson withdrew a net $91.7M in Q1 2015, closing 35 positions and reducing 75 holdings. Its most notable exit was Ecolab, an estimated $12.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 22% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Moody Lynn & Lieberson opened a new position in iShares MSCI Germany ETF worth $20.4M.

  • Moody Lynn & Lieberson's largest Q1 2015 buy was iShares MSCI Germany ETF: 683,561 shares worth $20.4M.
  • Moody Lynn & Lieberson added most to Vanguard FTSE Developed Markets ETF in Q1 2015, an estimated $16M increase.
  • Moody Lynn & Lieberson's biggest Q1 2015 reduction was Microsoft, cutting an estimated $16.7M.
  • Moody Lynn & Lieberson fully exited Ecolab in Q1 2015, selling an estimated $12.9M.
  • Moody Lynn & Lieberson's ten largest holdings make up 29% of its $627M portfolio in Q1 2015.
  • Moody Lynn & Lieberson opened 27 new positions and closed 35 in Q1 2015.
  • Moody Lynn & Lieberson's portfolio value fell 11% quarter-over-quarter to $627M.

Based on Moody Lynn & Lieberson's 13F filing for Q1 2015, filed 29 Apr 2015.